A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine
Clinical trial NCT01159743 · COMPLETED
Trial details
- NCT number
- NCT01159743
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-07-01
- Primary completion
- 2011-09-01
- Enrollment
- 346
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.